116 related articles for article (PubMed ID: 1226967)
1. [HBsAg and anti-HBs in chronic, inflammatory liver diseases].
Müller R; Stephan B; Deichler H
Verh Dtsch Ges Inn Med; 1975; 81():1363-5. PubMed ID: 1226967
[No Abstract] [Full Text] [Related]
2. Detection of hepatitis B virus DNA sequences in liver in HBsAg seronegative patients with liver disease with and without anti-HBc antibodies.
Fagan EA; Davison FD; Trowbridge R; Carman WF; Smith HM; Tedder R; Williams R
Q J Med; 1991 Feb; 78(286):123-34. PubMed ID: 2031075
[TBL] [Abstract][Full Text] [Related]
3. The significance of detailed hepatitis B virus serology in chronic liver diseases.
Horváth G; Tolvaj G; Stotz G; Dávid K
Acta Med Hung; 1992-1993; 49(1-2):119-28. PubMed ID: 1296181
[TBL] [Abstract][Full Text] [Related]
4. Australia antigen in Jerusalem.
Fainaru M; Gorsky Y
Isr J Med Sci; 1972 Jan; 8(1):7-10. PubMed ID: 5026866
[No Abstract] [Full Text] [Related]
5. [The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
Giuliani-Piccari G; Orlandi G; Roccuzzo S; D'Imperio N; Formica G; Piemontese A; Sarti F
G Clin Med; 1981 Feb; 62(2):94-102. PubMed ID: 7239059
[No Abstract] [Full Text] [Related]
6. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
8. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
Dávid K; Halmy L
Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
[TBL] [Abstract][Full Text] [Related]
9. [Detection of Australia antigen and corresponding antibodies during different diseases of the liver. Comparison of the technics used].
Lavillaureix L; Cvoric M; Lautier F; Stahl J
Nouv Presse Med; 1973 Mar; 2(9):580. PubMed ID: 4634051
[No Abstract] [Full Text] [Related]
10. Australia antigen and liver diseases. Report on personal cases and review of the literature.
Frosini G; Lombardini L; Marchi B; Toti M; Alegente G; Pippi L
Quad Sclavo Diagn; 1975 Dec; 11(4):770-85. PubMed ID: 1232643
[TBL] [Abstract][Full Text] [Related]
11. [Australia-antigen in patients with acute and chronic liver diseases].
Nielsen PE; Nielsen JO; Dietrichson O
Ugeskr Laeger; 1970 May; 132(19):875-9. PubMed ID: 5447319
[No Abstract] [Full Text] [Related]
12. Hepatitis B virus antigens in acute and chronic hepatitis and liver cirrhosis. Clinical, morphologic, enzymatic and immunologic analysis.
Nazarewicz T; Milewski B; Krawczyński K; Nowoslawski A
Mater Med Pol; 1975; 7(3):191-6. PubMed ID: 1177521
[No Abstract] [Full Text] [Related]
13. [Significance of detailed Hepatitis B virus marker studies in chronic liver diseases].
Horváth G; Tolvaj G; Dávid K
Orv Hetil; 1992 Jul; 133 Suppl 1():9-13. PubMed ID: 1630808
[TBL] [Abstract][Full Text] [Related]
14. [e/Anti-e system in liver disease].
Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus DNA detected by PCR in sera and liver tissues of Chinese patients with chronic liver diseases.
Zhang YY; Guo LS; Li L; Zhang YD; Hao LJ; Hansson BG; Nordenfelt E
Chin Med J (Engl); 1993 Jan; 106(1):7-12. PubMed ID: 8504690
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
Eleftheriou N; Thomas HC; Heathcote J; Sherlock S
Lancet; 1975 Dec; 2(7946):1171-3. PubMed ID: 53657
[TBL] [Abstract][Full Text] [Related]
17. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.
Gandhi RT; Wurcel A; Lee H; McGovern B; Boczanowski M; Gerwin R; Corcoran CP; Szczepiorkowski Z; Toner S; Cohen DE; Sax PE; Ukomadu C
Clin Infect Dis; 2003 Jun; 36(12):1602-5. PubMed ID: 12802762
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the presence of Australia antigen and some clinical and humoral features of various chronic liver diseases].
Coltorti M; Del Vecchio-Blanco C; Oriani GA; Carrella M
Minerva Med; 1972 Sep; 63(62):3367-75. PubMed ID: 4626800
[No Abstract] [Full Text] [Related]
19. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
20. [Detection and antigenic distribution of hepatitis B virus in liver tissue and its relation to other serological markers of viral replication].
Malavé C; Fernández de Aránguiz A; Sarria L; Ereño C; Campelo C; Gorriño MT; Suñén E; Cisterna R
Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):610-7. PubMed ID: 2098119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
